Research & Development
Alisa Lask is VP and GM, U.S. aesthetic business unit of Galderma, Nestlé Skin Health.
Elena Cant is VP, global head of vaccine commercial, Takeda Vaccine Business Unit of Takeda.
Deborah Profit is VP, Otsuka Information Technology at Ostuka.
Vanessa Thirion-Cullity is executive director, U.S. NET of Novartis Oncology.
Heather Bell is SVP, global head of digital and analytics of Sanofi.
Ryan Billings is the senior director, digital innovation at Amag Pharmaceuticals.
Ozgun Demir is the director, digital strategy at Novartis.
Pablo Graiver is CEO of Antidote.
Dr. Jessica Grossman is CEO of Medicines360.
Grant Groves is global customer innovation lab, U.S. lead at Boehringer Ingelheim.
Aaron Horowitz is cofounder and CEO of Sproutel.
Sarah Krug is CEO of Cancer101/Health Collaboratory.
Eddie Martucci is CEO of Akili Interactive Labs.
Joe Meadows is president of Think Patients.
Laurie Myers is global health literacy director of Merck.
Colleen Reinhart is director, patient marketing and therapy awareness, transcatheter heart valves at Edwards Lifesciences.
GCI Health, HealthyWomen, and Redbook magazine are using survey insights to inform the HealthiHer movement.
Jim Boushie, director of respiratory marketing at Boehringer Ingelheim (BI) and David Laros, VP of analytics and commercial effectiveness at Aptus Health, came together to lead a joint ePharma session in March titled "Synchronized HCP and consumer campaigns: At the point of care and beyond."
Marketers discuss the biggest catalysts for use of behavioral science techniques in marketing.
As researchers and analysts, we interact with a wide array of market research pros in the health and wellness space.
Novartis Oncology taps Pfizer exec as CEO; healthcare jobs become the largest source of U.S. employment; HHS nominee wary about drug-pricing negotiations
Cancer Research UK's 'Right Now' brand campaign will return in 2018 with a new focus highlighting the impact that research has on people suffering with cancer.
Pharma R&D return on investment falls to eight-year low; FDA approves Pfizer's biosimilar to J&J's Remicade; Novartis to downsize generics business
It turns out the real goal is going after Washington's favorite whipping boy — high drug prices.
FDA approves Novo's diabetes drug; Walgreens undergoes rebranding in the wake of CVS-Aetna merger; pharma increasingly transparent about clinical trial data
Our understanding of how cancer develops and thrives has grown.
Teva reports lower-than-expected Q3 earnings; BI and Dicerna partner in NASH drug development; AstraZeneca's experimental asthma drug fails in Phase-III
Do you recall what President Trump tweeted right after Merck's Kenneth Frazier resigned from his American Manufacturing Council?
Non-profit challenges Gilead's Sovaldi patent; The Medicines Company to cut hundreds of jobs; Amgen ends R&D for experimental CETP drug
Susan G. Komen and the Breast Cancer Research Foundation are focusing on raising awareness and research money for the deadliest forms of the disease.